<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gene amplification is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific event during <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have proposed a lineage-dependency (<z:mp ids='MP_0002555'>addiction</z:mp>) model of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> whereby amplification of certain lineage transcription factors predisposes a survival mechanism in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>These <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells are derived from tissues where the lineage factors play essential developmental and maintenance roles </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we show that recurrent amplification at 18q11.2 occurs in 21% of esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (EAC) </plain></SENT>
<SENT sid="4" pm="."><plain>Utilization of an integrative genomic strategy reveals a single gene, the embryonic endoderm transcription factor GATA6, as the selected target of the amplification </plain></SENT>
<SENT sid="5" pm="."><plain>Overexpression of GATA6 is found in EACs that contain gene amplification </plain></SENT>
<SENT sid="6" pm="."><plain>We find that EAC patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> carry GATA6 amplification have a poorer survival </plain></SENT>
<SENT sid="7" pm="."><plain>We show that ectopic expression of GATA6, together with FGFR2 isoform IIIb, increases anchorage-independent growth in immortalized Barrett's esophageal cells </plain></SENT>
<SENT sid="8" pm="."><plain>Conversely, siRNA-mediated silencing of GATA6 significantly reduces both cell proliferation and anchorage-independent growth in EAC cells </plain></SENT>
<SENT sid="9" pm="."><plain>We further demonstrate that induction of apoptotic/anoikis pathways is triggered upon silencing of GATA6 in EAC cells but not in esophageal squamous cells </plain></SENT>
<SENT sid="10" pm="."><plain>We show that activation of p38Î± signaling and up-regulation of TNF-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand are detected in apoptotic EAC cells upon GATA6 deprivation </plain></SENT>
<SENT sid="11" pm="."><plain>We conclude that selective gene amplification of GATA6 during EAC development sustains oncogenic lineage-survival of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>